Medical Division

A Healthier Life is Everyone's Wish.

Anti-adhesion film

Development of non-toxic synthetic materials and hydrogel film-type products that can control performance by application area with pure domestic technology

Anti-adhesion agent commercialization plan by year

2018~2022

  • Primary Thyroid Clinical
  • Clinical completion and GMP approval
  • Selection of vendor (pharmaceutical company)

2022~2024

  • Additional indications (3) clinical
  • FDA, CE approval
  • Overseas sales

2025~2027

  • Additional indications (3) clinical
  • Completed 7 indications in total
  • Launch of follow-up products, such as for sinuses

PEO-Guard clinical trial in progress

Hydrogel film-type product PEO-guard optimized for sales in overseas markets familiar with incisional surgery methods / Clinical trial in progress

Products Shape Performance Toxicity Circulation Manufacturing cost Export
PEO-guard Film High None Room temperature Low(innovation) Suitable
Domestic competitor Gel lowness None, Low Cold storage High Difficulty